carbamazepine has been researched along with Fatigue in 12 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Fatigue: The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We performed an observational study, collecting data between 2017 and 2019 on serum sodium levels and adverse effects retrospectively in people with epilepsy while receiving treatment with either carbamazepine (CBZ) or oxcarbazepine (OXC)." | 8.02 | Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. ( Berghuis, B; de Haan, GJ; Hulst, J; Koeleman, BPC; Lindhout, D; McCormack, M; Sander, JW; Sonsma, A, 2021) |
| "We performed an observational study, collecting data between 2017 and 2019 on serum sodium levels and adverse effects retrospectively in people with epilepsy while receiving treatment with either carbamazepine (CBZ) or oxcarbazepine (OXC)." | 4.02 | Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy. ( Berghuis, B; de Haan, GJ; Hulst, J; Koeleman, BPC; Lindhout, D; McCormack, M; Sander, JW; Sonsma, A, 2021) |
| " Memory alteration was least common with lamotrigine and oxcarbazepine, and there was less association between fatigues with oxcarbazepine/pregabalin." | 3.88 | Adverse effects of anti-epileptics in trigeminal neuralgiform pain. ( Cregg, R; Lee, G; O'Keeffe, AG; Reading, J; Tentolouris-Piperas, V; Zakrzewska, JM, 2018) |
| "Treatment with eslicarbazepine acetate was noninferior to BID carbamazepine-CR." | 2.87 | Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study. ( Ben-Menachem, E; Elger, C; Keller, B; Kowacs, PA; Löffler, K; Rocha, JF; Soares-da-Silva, P; Trinka, E, 2018) |
| " dosing schedule of the controlled-release (CR) preparation without a detrimental effect on seizure frequency or adverse effects." | 2.67 | A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine. ( Bruni, J; Dhalla, Z; Sutton, J, 1991) |
| "Levetiracetam was independently associated with anger/aggression, nervousness/agitation, upset stomach, depression, and sleep disturbance; lamotrigine with nervousness/agitation, upset stomach, and difficulty concentrating; and valproic acid with upset stomach and shaky hands." | 1.43 | Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study. ( Fidzinski, P; Gaus, V; Holtkamp, M; Kowski, AB; Losch, F; Weissinger, F, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Berghuis, B | 1 |
| Hulst, J | 1 |
| Sonsma, A | 1 |
| McCormack, M | 1 |
| de Haan, GJ | 1 |
| Sander, JW | 1 |
| Lindhout, D | 1 |
| Koeleman, BPC | 1 |
| Trinka, E | 1 |
| Ben-Menachem, E | 1 |
| Kowacs, PA | 1 |
| Elger, C | 1 |
| Keller, B | 1 |
| Löffler, K | 1 |
| Rocha, JF | 1 |
| Soares-da-Silva, P | 1 |
| Tentolouris-Piperas, V | 1 |
| Lee, G | 1 |
| Reading, J | 1 |
| O'Keeffe, AG | 1 |
| Zakrzewska, JM | 1 |
| Cregg, R | 1 |
| Weaver, D | 1 |
| Chorny, V | 1 |
| Tewari, S | 1 |
| Kowski, AB | 1 |
| Weissinger, F | 1 |
| Gaus, V | 1 |
| Fidzinski, P | 1 |
| Losch, F | 1 |
| Holtkamp, M | 1 |
| Wittchen, F | 1 |
| Spencker, S | 1 |
| Zinke, S | 1 |
| Coban, N | 1 |
| Schultheiss, HP | 1 |
| Witzenbichler, B | 1 |
| Silberstein, S | 1 |
| Saper, J | 1 |
| Berenson, F | 1 |
| Somogyi, M | 1 |
| McCague, K | 1 |
| D'Souza, J | 1 |
| Gillham, R | 1 |
| Baker, G | 1 |
| Thompson, P | 1 |
| Birbeck, K | 1 |
| McGuire, A | 1 |
| Tomlinson, L | 1 |
| Eckersley, L | 1 |
| Silveira, C | 1 |
| Brown, S | 1 |
| Dhalla, Z | 1 |
| Bruni, J | 1 |
| Sutton, J | 1 |
| Aarli, JA | 1 |
| Lehtovaara, R | 1 |
| Birket-Smith, E | 1 |
| Lund, M | 1 |
| Mikkelsen, B | 1 |
| Vestermark, S | 1 |
| Olsen, PZ | 1 |
| Holm, P | 1 |
5 trials available for carbamazepine and Fatigue
| Article | Year |
|---|---|
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazep | 2018 |
Oxcarbazepine in migraine headache: a double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dizziness; Dose-Response Relationship, Drug | 2008 |
Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments.
Topics: Adolescent; Adult; Affect; Aging; Anticonvulsants; Behavior; Carbamazepine; Cognition Disorders; Dou | 1996 |
A comparison of the efficacy and tolerability of controlled-release carbamazepine with conventional carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Ataxia; Attitude of Health Personnel; Attitude to Health; | 1991 |
A controlled trial on Ro 5-4023 (clonazepam) in the treatment of psychomotor epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepinones; Carbamazepine; Child; Chlorobenzenes; Clinica | 1973 |
7 other studies available for carbamazepine and Fatigue
| Article | Year |
|---|---|
Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Dizziness; Epilepsy; Fatigue; Female; Humans; Hyponatremia; M | 2021 |
Adverse effects of anti-epileptics in trigeminal neuralgiform pain.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Cross-Sectional Studies; Fatigue; Female; Humans; Lamot | 2018 |
Case 1: Joint Pain, Weight Loss, Fatigue, and Persistent Pleural Effusions in 17-year-old Boy.
Topics: Adolescent; Anticonvulsants; Arthralgia; Asthma; Carbamazepine; Diabetes Mellitus, Type 2; Diagnosis | 2015 |
Specific adverse effects of antiepileptic drugs--A true-to-life monotherapy study.
Topics: Adult; Aged; Anticonvulsants; Anxiety; Carbamazepine; Depression; Drug-Related Side Effects and Adve | 2016 |
[Chest pain, reduced physical activity, and polyserositis in a 35-year old patient with anticonvulsive medication].
Topics: Adult; Anticonvulsants; Carbamazepine; Chest Pain; Fatigue; Humans; Lupus Erythematosus, Systemic; M | 2006 |
Effect of clonazepam (Ro 5-4023) on epileptic seizures.
Topics: Adolescent; Adult; Anticonvulsants; Benzodiazepinones; Carbamazepine; Chlorobenzenes; Drug Evaluatio | 1973 |
A clinical trial with clonazepam (Ro 5-4023).
Topics: Adolescent; Adult; Anticonvulsants; Barbiturates; Benzodiazepinones; Carbamazepine; Child; Chloroben | 1973 |